In today's trading, shares of Eupraxia Pharmaceuticals Inc opened at $3.70 and closed at $3.60. It traded at a low of $3.55 to a high of $3.70.

The price eased -1.37% from the previous day's close of $3.65.

During the day across North America, the TSX Composite closed -0.45% at 21642.87, the S&P 500 closed -0.21% at 5051.41, the Dow Jones Industrial Average closed 0.17% at 37798.97 and the Nasdaq Composite closed -0.12% at 15865.25.

Eupraxia Pharmaceuticals Inc traded under EPRX on the Toronto Stock Exchange (TSX).

A total of 57,300 shares was traded during the session, with total trades of 83. On average, Eupraxia Pharmaceuticals Inc has traded 65,166 shares over the last 5-days and 56,361 year-to-date.

Trading across the entire TSX saw 2,131 price advancers against 3,083 declines and 114 unchanged.

During the prior 52 weeks, EPRX.TO has traded as high as $9.10 (July 05,2023) and low as $3.55 (April 17,2024). Moreover, the shares have shrunken -26.38 percent in 52 weeks, while they have shrunken -32.96% year-to-date.

Following today's trading, Eupraxia Pharmaceuticals Inc has a market capitalization of $130.02 million on a float of 35,623 shares outstanding. Its annual EPS is $-1.53.

Eupraxia Pharmaceuticals Inc is a TSX Biotechnology company headquartered in Victoria, CAN.

Currently, Eupraxia Pharmaceuticals Inc has an average recommendation of "Strong Sell" based on 0.00 analysts according to Zacks. From those 0 analysts,.

AI at The Globe and Mail
This report is produced using automated technology that summarizes market data into articles for our readers. Ongoing project experiments that leverage artificial intelligence include valuation screens across 14 categories and end-of-day Closing Summary reports for all North American securities..